Effectiveness of Multiple Daily Injections or Continuous Subcutaneous Insulin Infusion for Children with Type 1 Diabetes Mellitus in Clinical Practice

Table 1

General clinical data at baseline.

	Group 1			Group 2
	Group 1A	Group 1B		Group 2A	Group 2B
Males/females (n)	29/32	56/66	0.40	13/10	24/22	0.73
Age (years)	7.29 ± 3.99	8.61 ± 3.08	0.14	10.50 ± 2.78	10.35 ± 2.73	0.84
Disease duration (months)	1.72 ± 2.43	1.77 ± 2.42	0.90	21.09 ± 5.54	21.00 ± 5.72	0.95
Glycosylated hemoglobin level (%)	8.03 ± 1.41	8.01 ± 1.92	0.93	8.39 ± 1.23	8.67 ± 1.44	0.44
Abnormal glycemic control rate (%)	18.0	22.1	0.52	30.4	45.7	0.23
BMI (kg/m^2)	16.74 ± 2.26	16.57 ± 1.92	0.61	17.54 ± 1.97	17.12 ± 2.45	0.48
Insulin dosage (U/kg/d)	0.59 ± 0.36	0.39 ± 0.24	<0.01	0.58 ± 0.27	0.66 ± 0.23	0.19
Blood glucose monitoring ≥4 times/day (%)	76.3	62	0.15	70	31.3	0.13

*Group 1A versus group 1B; ^†group 2A versus group 2B.